March 19, 2024
ASKA Pharmaceutical said on March 18 that it has concluded a collaborative research pact with Red Arrow Therapeutics, a US-headquartered University of Tokyo spinout, to develop a new treatment for preeclampsia employing advanced nanotechnology. The company did not disclose the...read more